507 related articles for article (PubMed ID: 18803942)
1. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
[TBL] [Abstract][Full Text] [Related]
2. Hyperthyroidism is associated with higher plasma endothelin-1 concentrations.
Chu CH; Lee JK; Keng HM; Chuang MJ; Lu CC; Wang MC; Sun CC; Wei MC; Lam HC
Exp Biol Med (Maywood); 2006 Jun; 231(6):1040-3. PubMed ID: 16741045
[TBL] [Abstract][Full Text] [Related]
3. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
[TBL] [Abstract][Full Text] [Related]
4. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
Oki K; Yamane K; Kamei N; Nojima H; Kohno N
Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
[TBL] [Abstract][Full Text] [Related]
6. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of the adipokine visfatin are increased in pre-eclampsia.
Fasshauer M; Waldeyer T; Seeger J; Schrey S; Ebert T; Kratzsch J; Lossner U; Bluher M; Stumvoll M; Faber R; Stepan H
Clin Endocrinol (Oxf); 2008 Jul; 69(1):69-73. PubMed ID: 18034779
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
[TBL] [Abstract][Full Text] [Related]
9. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
10. Increase in visfatin after weight loss induced by gastroplastic surgery.
Krzyzanowska K; Mittermayer F; Krugluger W; Kopp HP; Schernthaner G
Obesity (Silver Spring); 2006 Nov; 14(11):1886-9. PubMed ID: 17135602
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
12. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
[TBL] [Abstract][Full Text] [Related]
13. [Insulin resistance assessed with HOMA-IR in hyperthyroid patients].
Owecki M; Nikisch E; Sowiński J
Pol Merkur Lekarski; 2005 Nov; 19(113):617-20. PubMed ID: 16498796
[TBL] [Abstract][Full Text] [Related]
14. Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy.
Eyileten T; Sonmez A; Saglam M; Cakir E; Caglar K; Oguz Y; Vural A; Yenicesu M; Yilmaz MI
Nephrology (Carlton); 2010 Mar; 15(2):225-9. PubMed ID: 20470283
[TBL] [Abstract][Full Text] [Related]
15. Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers.
Bo S; Ciccone G; Baldi I; Gambino R; Mandrile C; Durazzo M; Gentile L; Cassader M; Cavallo-Perin P; Pagano G
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):423-30. PubMed ID: 19073361
[TBL] [Abstract][Full Text] [Related]
16. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance is associated with circulating fibrinogen levels in nondiabetic patients receiving peritoneal dialysis.
Martins C; Mazza do Nascimento M; Pecoits-Filho R; Leinig C; Gonçalves LF; Fuerbringer R; Stenvinkel P; Lindholm B; Riella MC
J Ren Nutr; 2007 Mar; 17(2):132-7. PubMed ID: 17321953
[TBL] [Abstract][Full Text] [Related]
18. Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability.
Chen JL; Chiu HW; Tseng YJ; Chu WC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):611-6. PubMed ID: 16712661
[TBL] [Abstract][Full Text] [Related]
19. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.
Gen R; Akbay E; Muslu N; Sezer K; Cayan F
Gynecol Endocrinol; 2009 Apr; 25(4):241-5. PubMed ID: 19408173
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
